antiviral

Glowing puzzle piece fitting into puzzle
Biotech

Gilead pumps up virology pipeline with drug transporter deal

Gilead is paying Health Hope Pharma $10 million upfront for global rights to a candidate in virology.
Nick Paul Taylor Sep 29, 2025 10:35am
RSV

Enanta sees RSV drug fail phase 2b but finds positives

Sep 29, 2025 8:05am
arrow back backwards u-turn turn around reverse

Ascletis slashes funds for former core programs in obesity pivot

Mar 26, 2025 10:00am
RSV virus

Shionogi's RSV antiviral reduces viral load in ph. 2 adult trial

Jan 30, 2025 5:32am
Silhouette of multiple thumbs ups against the sky

AI drug discoverer's antiviral reduces COVID in mouse lungs

Jan 21, 2025 12:42am
COVID-19 danger coronavirus pandemic quarantine

Atea's COVID antiviral fails to halt hospitalizations in phase 3

Sep 13, 2024 10:10am